William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
ServiceMax to Be Listed on Nasdaq following Business Combination with Pathfinder Acquisition (PFDR)
-
ServiceMax, a Leader in Field Service Management SaaS, to Be Listed on Nasdaq following Business Combination with Pathfinder Acquisition Corporation
-
Membership Collective Group (MCG) IPO Opens 6% Lower
-
Sera Prognostics (SERA) IPO Opens Lower
-
Sera Prognostics Inc (SERA) Prices 4.7M Share IPO at $16/sh
-
Membership Collective Group INC. Announces Pricing of Initial Public Offering
-
Sera Prognostics Announces Pricing of Initial Public Offering
-
Sera Prognostics Announces Pricing of Initial Public Offering
-
Markforged Announces Listing on New York Stock Exchange Under Ticker Symbol “MKFG”
-
William Blair Downgrades Lennox International (LII) to Market Perform, Following Management Change Announcement
-
Beacon Roofing Supply (BECN) EPS Raised Above Consensus After Survey Shows Strong Demand With No End In Sight - William Blair
-
Vestar Capital Partners to Make Majority Investment in PetHonesty, a Leader in Premium Pet Supplements
-
Ramaco Resources, Inc. Completes $34,500,000 Senior Unsecured Notes Offering
-
William Blair Downgrades Welbilt, Inc. (WBT) to Market Perform, Following Takeover Related Business Update
-
William Blair Investment Management Hires Vesta Marks as U.S. Fixed Income Portfolio Manager
-
Instructure (INST) Launches 12.5M Share IPO at $19-$21/sh
-
Instructure Announces Launch of Initial Public Offering
-
Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
-
Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
-
UPDATE: William Blair Starts Kinnate Biopharma (KNTE) at Outperform
-
Ryan Specialty Announces Launch of Initial Public Offering
-
Prospect Capital Announces Pricing of $150 Million in Aggregate Liquidation Preference of 5.35% Series A Perpetual Preferred Stock
-
Prospect Capital Announces Pricing of $150 Million in Aggregate Liquidation Preference of 5.35% Series A Perpetual Preferred Stock
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021
-
EmpiRx Health Announces Strategic Growth Investment from Nautic Partners
-
Recruiter.com Group (RCRT) Acquires Uncubed's Technology Solutions Business
-
Recruiter.com Acquires Uncubed's Technology Solutions Business
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Neurana Pharmaceuticals to Participate at William Blair Biotech Conference
-
Aptinyx to Participate in William Blair Biotech Focus Conference 2021
-
Thoma Bravo Completes Strategic Growth Investment in Greenphire
-
ViaSat (VSAT) Likely to Benefit From President Biden's Executive Order to DOT
-
Lyra Therapeutics to Present at Upcoming Virtual Healthcare Conference
-
Lyra Therapeutics to Present at Upcoming Virtual Healthcare Conference
-
Atea Pharmaceuticals to Present at William Blair Biotech Focus Conference
-
Charlesbank To Make A Strategic Investment In Clearlake And SkyKnight-Backed symplr
-
UPDATE: William Blair Starts Verve Therapeutics (VERV) at Outperform
-
MaxCyte, Inc (MXCT) Files up to $100M IPO
-
MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing
-
8 Hot Penny Stocks on Robinhood That You Need to Know About
-
Form D/A William Blair Macro Allo

